NextCure Inc (NXTC)

The most recent insider trading activity at NextCure Inc. occurred on November 15, 2019, with a significant buy transaction by Sofinnova Venture Partners IX, L.P. This transaction involved 150,000 shares valued at $5,512,500. Prior to this, several other buy transactions took place in May 2019, indicating consistent insider purchasing.
Stock chart
Ticker: NXTC Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sofinnova Venture Partners IX, L.P.
1 purchase — total 5,512,500 USD
Buy 15 Nov 2019
Value US$4,304,036.75 | Price 232.10 | Shares 24,881
Buy 13 May 2019
Value US$1,827,520.22 | Price 392.62 | Shares 70,639
Buy 13 May 2019
Value US$750,000.00 | Price 15.00 | Shares 50,000
Buy 13 May 2019
Value US$1,875,000.00 | Price 15.00 | Shares 125,000
Buy 13 May 2019
Value US$5,250,000.00 | Price 15.00 | Shares 350,000
Buy 13 May 2019
Value US$750,000.00 | Price 15.00 | Shares 50,000
Buy 13 May 2019
Value US$5,250,000.00 | Price 15.00 | Shares 350,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2019-11-19 2019-11-15 B Purchase Sofinnova Venture Partners IX, L.P. Large shareholder
24,881 +26.2%
232.10
US$4,304,037
24,881 +26.2% 232.10 US$4,304,037
2019-05-15 2019-05-13 B Purchase Large shareholder
70,639 +6.6%
392.62
US$1,827,520
70,639 +6.6% 392.62 US$1,827,520
2019-05-13 2019-05-13 B Purchase Large shareholder
81,710 -26.2%
16.47
US$2,530,434
81,710 -26.2% 16.47 US$2,530,434
2019-05-13 2019-05-13 B Purchase
125,000 +12.8%
15.00
US$1,875,000
125,000 +12.8% 15.00 US$1,875,000
2019-05-13 2019-05-13 B Purchase
350,000 +14.8%
15.00
US$5,250,000
350,000 +14.8% 15.00 US$5,250,000
2019-05-13 2019-05-13 B Purchase Non-Executive Director
50,000 +2.3%
15.00
US$750,000
50,000 +2.3% 15.00 US$750,000
2019-05-13 2019-05-13 B Purchase Non-Executive Director Large shareholder
350,000 +14.8%
15.00
US$5,250,000
350,000 +14.8% 15.00 US$5,250,000